Stay updated on Safety Tolerance Efficacy in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerance Efficacy in IPF Clinical Trial page.

Latest updates to the Safety Tolerance Efficacy in IPF Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page removes the 'Interstitial lung disease 2' item and the 'Genetic and Rare Diseases Information Center' resource. This could affect navigation and access to related information.SummaryDifference0.2%

- Check19 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This is a metadata version update and does not alter study data, eligibility criteria, locations, or results.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision: v3.4.3 has been added and Revision: v3.4.2 has been removed. This update appears to be a backend version change with no visible changes to the study details.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.4.2 was added to the page history. The notice about a lapse in government funding and the previous Revision: v3.4.1 entry were removed.SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a government funding notice about potential data inaccuracy and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check68 days agoChange DetectedAdded a Show glossary option and minor wording/casing changes for QC labels (Last Update Submitted that Met QC Criteria vs Last Update Submitted that met QC Criteria), along with the No FEAR Act Data labeling. The Revision was updated from v3.3.4 to v3.4.0.SummaryDifference0.2%

Stay in the know with updates to Safety Tolerance Efficacy in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerance Efficacy in IPF Clinical Trial page.